NNOX
Get informed when a big investor buys or sells
+ FollowOvervalued by 436.2% based on the discounted cash flow analysis.
| Market cap | $116.22 Million |
|---|---|
| Enterprise Value | $74.92 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.16 |
| Beta | 1.17 |
| Outstanding Shares | 67,059,000 |
| P/E Ratio | -1.49 |
|---|---|
| PEG | -1.09 |
| Price to Sales | - |
| Price to Book Ratio | 0.79 |
| Enterprise Value to Revenue | 5.75 |
| Enterprise Value to EBIT | -1.26 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.06 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3971▼ 93.34% |
|---|---|
| Total Calls | 685,200▲ 388.03% |
| Total Puts | 272,100▲ 45.66% |
Holdings and activity of institutional investors.
| Ownership % | 27.84%▲ 2.52% |
|---|---|
| Total Invested | $40.69M▼ 10.76% |
| Investors Holding | 132▲ 17.00% |
No data
Nano-X Imaging Ltd operates as a medical imaging technology company. The Company offers cloud-based image analysis, online diagnosis, and billing services. Nano-X Imaging serves governments, hospitals, and clinic chains in Israel.